These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23893802)

  • 21. Using a CD45dim/CD123bright/HLA-DRneg phenotyping protocol to gate basophils in FC for airway allergy. CD123 does not decrease.
    Chirumbolo S; Bjorklund G; Vella A
    Adv Respir Med; 2017; 85(4):193-201. PubMed ID: 28871586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reliability of basophil activation test using CD203c expression in diagnosis of pollen allergy.
    Özdemir SK; Güloğlu D; Sin BA; Elhan AH; Ikincioğulları A; Mısırlıgil Z
    Am J Rhinol Allergy; 2011; 25(6):e225-31. PubMed ID: 22185730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and management of hypersensitivity reactions to vaccines.
    Sarti L; Lezmi G; Mori F; Giovannini M; Caubet JC
    Expert Rev Clin Immunol; 2020 Sep; 16(9):883-896. PubMed ID: 32838592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Surveillance of adverse events following immunization in Henan Province, China between 2010-2011].
    Ye Y; Wang CS; Ma YT; Lu MX; Zhang XX; Zhang YY; Guo WS
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):466-71. PubMed ID: 23791064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric analysis of in vitro activated basophils, specific IgE and skin tests in the diagnosis of pollen-associated food allergy.
    Ebo DG; Hagendorens MM; Bridts CH; Schuerwegh AJ; De Clerck LS; Stevens WJ
    Cytometry B Clin Cytom; 2005 Mar; 64(1):28-33. PubMed ID: 15668987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The basophil activation test in immediate-type drug allergy.
    Hausmann OV; Gentinetta T; Bridts CH; Ebo DG
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):555-66. PubMed ID: 19563997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometric basophil activation test: a review.
    Sanz ML; Maselli JP; Gamboa PM; Oehling A; Diéguez I; de Weck AL
    J Investig Allergol Clin Immunol; 2002; 12(3):143-54. PubMed ID: 12530113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basophil activation and sulfidoleukotriene production in patients with immediate allergy to betalactam antibiotics and negative skin tests.
    Gamboa PM; García-Avilés MC; Urrutia I; Antépara I; Esparza R; Sanz ML
    J Investig Allergol Clin Immunol; 2004; 14(4):278-83. PubMed ID: 15736712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of basophil activation test in special populations with mastocytosis and reactions to hymenoptera sting.
    Bonadonna P; Zanotti R; Melioli G; Antonini F; Romano I; Lenzi L; Caruso B; Passalacqua G
    Allergy; 2012 Jul; 67(7):962-5. PubMed ID: 22676063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An algorithm for treatment of patients with hypersensitivity reactions after vaccines.
    Wood RA; Berger M; Dreskin SC; Setse R; Engler RJ; Dekker CL; Halsey NA;
    Pediatrics; 2008 Sep; 122(3):e771-7. PubMed ID: 18762513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The benefits of using basophil activation test as a diagnostic tool prior to specific immunotherapy with inhalant allergens].
    Czarnobilska E; Gregorius A; Porebski G; Spiewak R; Sacha M
    Przegl Lek; 2012; 69(12):1249-53. PubMed ID: 23750433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basophil Activation Test and specific IgE measurements using a panel of recombinant natural rubber latex allergens to determine the latex allergen sensitization profile in children.
    Sanz ML; García-Avilés MC; Tabar AI; Anda M; García BE; Barber D; Salcedo G; Rihs HP; Raulf-Heimsoth M
    Pediatr Allergy Immunol; 2006 Mar; 17(2):148-56. PubMed ID: 16618365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The complex link between immunization against childhood diseases and allergy.
    Kalaboka S; Annesi-Maesano I
    Expert Rev Vaccines; 2007 Aug; 6(4):635-43. PubMed ID: 17669015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy.
    Ebo DG; Hagendorens MM; Schuerwegh AJ; Beirens LM; Bridts CH; De Clerck LS; Stevens WJ
    Cytometry B Clin Cytom; 2007 May; 72(3):196-203. PubMed ID: 17111386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro analysis of birch-pollen-associated food allergy by use of recombinant allergens in the basophil activation test.
    Erdmann SM; Sachs B; Schmidt A; Merk HF; Scheiner O; Moll-Slodowy S; Sauer I; Kwiecien R; Maderegger B; Hoffmann-Sommergruber K
    Int Arch Allergy Immunol; 2005 Mar; 136(3):230-8. PubMed ID: 15713985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of immediate-type beta-lactam allergy in vitro by flow-cytometric basophil activation test and sulfidoleukotriene production: a multicenter study.
    De Week AL; Sanz ML; Gamboa PM; Aberer W; Sturm G; Bilo MB; Montroni M; Blanca M; Torres MJ; Mayorga L; Campi P; Manfredi M; Drouet M; Sainte-Laudy J; Romano A; Merk H; Weber JM; Jermann TM;
    J Investig Allergol Clin Immunol; 2009; 19(2):91-109. PubMed ID: 19476013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of the CD63 basophil activation test in detecting Anisakis hypersensitivity in patients with chronic urticaria: diagnosis and follow-up.
    Frezzolini A; Cadoni S; De Pità O
    Clin Exp Dermatol; 2010 Oct; 35(7):765-70. PubMed ID: 19874355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biologically plausible and evidence-based risk intervals in immunization safety research.
    Rowhani-Rahbar A; Klein NP; Dekker CL; Edwards KM; Marchant CD; Vellozzi C; Fireman B; Sejvar JJ; Halsey NA; Baxter R;
    Vaccine; 2012 Dec; 31(1):271-7. PubMed ID: 22835735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Causality assessment of adverse events following immunization: the problem of multifactorial pathology.
    Bellavite P
    F1000Res; 2020; 9():170. PubMed ID: 32269767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].
    Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S
    Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.